MDT Quote, Financials, Valuation and Earnings

Boston Scientific Corp. has a net margin of 15.42% compared to Medtronic Plc's net margin of 14.91%. Medtronic Plc's return on equity of 9.84% beat Boston Scientific Corp.'s return on equity of 12.46%.

Medtronic Plc has a consensus price target of $110.97, signalling upside risk potential of 12.51%. On the other hand Boston Scientific Corp. has an analysts' consensus of $125.86 which suggests that it could grow by 31.64%. Given that Boston Scientific Corp. has higher upside potential than Medtronic Plc, analysts believe Boston Scientific Corp. is more attractive than Medtronic Plc.

Medtronic Plc has a beta of 0.710, which suggesting that the stock is 28.968% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Boston Scientific Corp. quarterly revenues of $5.1B. Medtronic Plc's net income of $1.4B is higher than Boston Scientific Corp.'s net income of $755M. Notably, Medtronic Plc's price-to-earnings ratio is 26.64x while Boston Scientific Corp.'s PE ratio is 51.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.65x versus 7.38x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Globus Medical, Inc. has a net margin of 15.42% compared to Medtronic Plc's net margin of 15.47%. Medtronic Plc's return on equity of 9.84% beat Globus Medical, Inc.'s return on equity of 10.08%.

Medtronic Plc has a consensus price target of $110.97, signalling upside risk potential of 12.51%. On the other hand Globus Medical, Inc. has an analysts' consensus of $98.73 which suggests that it could grow by 13.4%. Given that Globus Medical, Inc. has higher upside potential than Medtronic Plc, analysts believe Globus Medical, Inc. is more attractive than Medtronic Plc.

Medtronic Plc has a beta of 0.710, which suggesting that the stock is 28.968% less volatile than S&P 500. In comparison Globus Medical, Inc. has a beta of 1.070, suggesting its more volatile than the S&P 500 by 7.046%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. Globus Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Globus Medical, Inc. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Globus Medical, Inc. quarterly revenues of $769M. Medtronic Plc's net income of $1.4B is higher than Globus Medical, Inc.'s net income of $119M. Notably, Medtronic Plc's price-to-earnings ratio is 26.64x while Globus Medical, Inc.'s PE ratio is 28.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.65x versus 4.33x for Globus Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical, Inc. has a net margin of 15.42% compared to Medtronic Plc's net margin of 28.31%. Medtronic Plc's return on equity of 9.84% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.

Medtronic Plc has a consensus price target of $110.97, signalling upside risk potential of 12.51%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $599.60 which suggests that it could grow by 4.74%. Given that Medtronic Plc has higher upside potential than Intuitive Surgical, Inc., analysts believe Medtronic Plc is more attractive than Intuitive Surgical, Inc..

Medtronic Plc has a beta of 0.710, which suggesting that the stock is 28.968% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Intuitive Surgical, Inc. quarterly revenues of $2.5B. Medtronic Plc's net income of $1.4B is higher than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, Medtronic Plc's price-to-earnings ratio is 26.64x while Intuitive Surgical, Inc.'s PE ratio is 75.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.65x versus 21.66x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Stryker Corp. has a net margin of 15.42% compared to Medtronic Plc's net margin of 14.18%. Medtronic Plc's return on equity of 9.84% beat Stryker Corp.'s return on equity of 14.06%.

Medtronic Plc has a consensus price target of $110.97, signalling upside risk potential of 12.51%. On the other hand Stryker Corp. has an analysts' consensus of $428.11 which suggests that it could grow by 20.53%. Given that Stryker Corp. has higher upside potential than Medtronic Plc, analysts believe Stryker Corp. is more attractive than Medtronic Plc.

Medtronic Plc has a beta of 0.710, which suggesting that the stock is 28.968% less volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.890, suggesting its less volatile than the S&P 500 by 11.047%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. Stryker Corp. offers a yield of 0.95% to investors and pays a quarterly dividend of $0.84 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Stryker Corp. pays out 41.74% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Stryker Corp. quarterly revenues of $6.1B. Medtronic Plc's net income of $1.4B is higher than Stryker Corp.'s net income of $859M. Notably, Medtronic Plc's price-to-earnings ratio is 26.64x while Stryker Corp.'s PE ratio is 46.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.65x versus 5.63x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.